A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations

Title
A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations
Authors
Keywords
Advanced non-small-cell lung cancer, First-line chemotherapy, EGFR, mutations, Afatinib, Elderly patients
Journal
LUNG CANCER
Volume 126, Issue -, Pages 41-47
Publisher
Elsevier BV
Online
2018-10-13
DOI
10.1016/j.lungcan.2018.10.014

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now